Ivermectin – Page 9 – Communicable Diseases Research

Moxidectin and Ivermectin Inhibit SARS-CoV-2 Replication in Vero E6 Cells but Not in Human Primary Bronchial Epithelial Cells

목시덱틴과 이버멕틴은 Vero E6 세포에서 SARS-CoV-2 복제를 억제하지만 인간의 1차 기관지 상피 세포에서는 억제하지 않습니다

Article

Published on 2022-01-182022-09-11
Journal: Antimicrobial Agents and Chemotherapy [Category] SARS, 치료제,

Ivermectin Prophylaxis Used for COVID-19: A Citywide, Prospective, Observational Study of 223,128 Subjects Using Propensity Score Matching

Infectious Disease

Published on 2022-01-152022-10-31
Journal: Cureus [Category] COVID-19,

[키워드] 95% CI 95% confidence interval absence adjusted age Analysis analyzed approval automatically baseline Brazil clinical Cohort Comorbidities conducted contraindications coronavirus coronavirus disease COVID-19 COVID-19 infection COVID-19 mortality death demonstrated dose Efficacy evaluate Hospitalization infected patient Infection infection rate information Ivermectin matching material mechanism medication mortality rate mortality rates occurred offered outcome prevention propensity score matching Prophylactic Prophylaxis Prospective PROTECT PSM real time reduced reduction in reduction in mortality registry data reported safety profile SARS-CoV-2 score Sex significantly subject subsequent Treatment variables were infected with COVID-19
[DOI] 10.7759/cureus.21272 PMC 바로가기 [Article Type] Infectious Disease

Ivermectin as an endectocide may boost control of malaria vectors in India and contribute to elimination

이버멕틴은 내외부 기생충 구제제로서 인도에서 말라리아 매개체의 통제를 강화하고 퇴치를 기여할 수 있습니다.

Review

Published on 2022-01-102024-08-08
Journal: Parasites & Vectors [Category] 말라리아,

[키워드] Endectocide Ivermectin Malaria elimination vector control
[DOI] 10.1186/s13071-021-05124-3 PMC 바로가기 [Article Type] Review

Brazilian Guidelines for the pharmacological treatment of patients hospitalized with COVID-19: Joint guideline of Associação Brasileira de Medicina de Emergência, Associação de Medicina Intensiva Brasileira, Associação Médica Brasileira, Sociedade Brasileira de Angiologia e Cirurgia Vascular, Sociedade Brasileira de Infectologia, Sociedade Brasileira de Pneumologia e Tisiologia, Sociedade Brasileira de Reumatologia

COVID-19로 입원한 환자의 약리학적 치료에 대한 브라질 지침: Associação Brasileira de Medicina de Emergência, Associação de Medicina Intensiva Brasileira, Associação Médica Brasileira, Sociedade Brasileira de Angiologia e Ciruracied Vasileira 공동 지침 Pneumologia e Tisiologia, Sociedade Brasileira de Reumatologia

Article

Published on 2022-01-012022-09-12
Journal: Revista Brasileira de Terapia Intensiva [Category] 진단,

[키워드] Antibiotics Anticoagulant Bacterial infection Brazil Colchicine convalescent plasma Corticosteroid corticosteroide COVID-19 develop dose drug effective Effectiveness English Evidence guideline hospitalized patient include infecção International Ivermectin lack lopinavir + ritonavir lopinavir/ ritonavir Ministry of Health oxygen pacientes hospitalizado Patient patients hospitalized pharmacological treatment plasma platform Prevent promote prophylactic dose Prophylaxis recommendation resource Strong supplemental oxygen Support supported therapy Thromboembolism Tocilizumab Tocilizumabe Treatment use of corticosteroid use of hydroxychloroquine with COVID-19
[DOI] 10.5935/0103-507X.20220001-pt PMC 바로가기 [Article Type] Article

Chemoprophylaxis against COVID-19 among health-care workers using Ivermectin in low- and middle-income countries: A systematic review and meta-analysis

Article

Published on 2021-12-302023-06-15
Journal: Indian journal of pharmacology [Category] MERS, SARS,

[키워드] Chemoprophylaxis coronavirus disease-2019 prevention Health-care workers Ivermectin resource-limited settings
[DOI] 10.4103/ijp.ijp_117_21 PMC 바로가기

Channels and Transporters of the Pulmonary Lamellar Body in Health and Disease

Review

Published on 2021-12-242022-10-31
Journal: Cells [Category] COVID-19, SARS,

The mechanisms of action of ivermectin against SARS-CoV-2—an extensive review

Reviews

Published on 2021-12-212022-10-05
Journal: The Journal of Antibiotics [Category] 신약개발, 치료제,

[키워드] cellular Complication COVID-19 pandemic COVID-19 pathogenesis drug host cell Interaction Ivermectin mechanism mutant strain novel coronaviruses SARS-CoV-2 urgency
[DOI] 10.1038/s41429-021-00491-6 [Article Type] Reviews

An update of anti-viral treatment of COVID-19

COVID-19의 항바이러스 치료 업데이트

Review

Published on 2021-12-172022-09-10
Journal: Turkish Journal of Medical Sciences [Category] SARS, 치료제,

[키워드] ACE-2 Administered Anti-viral treatment Antiviral AT-527 biological processe biological processes bromhexine camostat clinical trial clinical trials convalescent plasma COVID-19 drug dutasteride early phase effective effective antiviral treatment evaluated Favipiravir fluvoxamine group Host host protein host proteins human cell Hydroxychloroquine include inhibitor inhibitors interfere interferons Ivermectin knowledge Laboratory lactoferrin Lopinavir Lopinavir/ritonavir merimepodib molnupiravir moment monoclonal antibodies monoclonal antibody nanobodies natural immunity niclosamide nitazoxanide pandemic PF-07304814 PF-07321332 Plitidepsin protease Protein Proteins proxalutamide PTC299 RCTs Remdesivir Result Ritonavir RNA SARS-CoV-2 subject Support target protein target proteins the disease to define Treatment treatment for COVID-19 treatment of COVID-19 Trial umifenovir Viral viral entry Viral RNA virus
[DOI] 10.3906/sag-2106-250 PMC 바로가기 [Article Type] Review

Regional drug information center disseminates educational materials related to the COVID-19 pandemic

Research article

Published on 2021-12-012022-10-05
Journal: Exploratory Research in Clinical and Social Pharmacy [Category] 치료제,

[키워드] COVID-19 COVID-19 pandemic develop disseminate dissemination drug Drug information services explained expressed Health Health Education identify indicate information Ivermectin media objective pandemic Pharmacist produced question reached Regional Result supported tested Treatment Vaccine
[DOI] 10.1016/j.rcsop.2021.100080 [Article Type] Research article

Single-dose oral ivermectin in mild and moderate COVID-19 (RIVET-COV): A single-centre randomized, placebo-controlled trial

Randomized Controlled Trial

Published on 2021-12-012022-10-05
Journal: Journal of infection and chemotherapy : official j [Category] SARS, 신약개발, 임상,

[키워드] acute respiratory syndrome administration Analysis antiparasitic drug Arm assigned Coronavirus-2 COVID-19 dose double blind Efficacy enrolment hospitalized patient in viral In-vitro intention-to-treat population Intervention Ivermectin Mild Mild-to-moderate Moderate COVID-19 modified intention-to-treat negativity occurred outcome Patient patients randomized Placebo placebo-controlled trial positive RT-PCR Primary outcome Randomized Randomized controlled trial reducing RT-PCR Safety SARS-CoV-2 Serious Adverse Event Serious Adverse Events significantly Single-dose statistical significance treating COVID-19 Viral load were assessed
[DOI] 10.1016/j.jiac.2021.08.021 PMC 바로가기 [Article Type] Randomized Controlled Trial